Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study

Background Psychosis is rare in untreated patients with Parkinson's disease (PD) but the prevalence rises to 40% during dopaminergic treatment. So far, no systematic comparison of the psychogenic potential of different dopaminergic drugs had been performed.